Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
BMJ (Clinical Research Ed.)
|
February 7, 2004
Volunteer counsellors for supporting breast feeding: support for breast feeding must be proactive
Annette E Hay
Hematology/Oncology Clinics of North America
|
November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone
Annette E Hay, Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectiveness
Annette E Hay, Ralph M Meyer
Journal of Medical Economics
|
February 13, 2019
CAR T-cells: costs, comparisons, and commentary
Annette E Hay, Matthew C Cheung
Haematologica
|
November 9, 2004
Latency of onset of de novo myelodysplastic syndromes
Pei-shan Wu, Annette E Hay, Giles E Thomas, et al.
BMC Medical Research Methodology
|
August 3, 2023
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
Louis Everest, Bingshu E Chen, Annette E Hay, et al.
BMJ Open
|
August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities
Brooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Canadian Journal of Diabetes
|
January 11, 2024
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study
Sarah Moore-Vasram, Monakshi Sawhney, Robyn L Houlden, et al.
Leukemia & Lymphoma
|
July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trial
Abi Vijenthira, Xinzhi Li, Michael Crump, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
People Living with HIV Eligibility in Canadian Cancer Clinical Trials
Maria F Comelles, Santiago Perez-Patrigeon, Tessa Senneker, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
BMJ (Clinical Research Ed.)
|
February 7, 2004
Volunteer counsellors for supporting breast feeding: support for breast feeding must be proactive
Annette E Hay
Hematology/Oncology Clinics of North America
|
November 30, 2013
Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone
Annette E Hay, Ralph M Meyer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2012
Hepatitis B, rituximab, screening, and prophylaxis: effectiveness and cost effectiveness
Annette E Hay, Ralph M Meyer
Journal of Medical Economics
|
February 13, 2019
CAR T-cells: costs, comparisons, and commentary
Annette E Hay, Matthew C Cheung
Haematologica
|
November 9, 2004
Latency of onset of de novo myelodysplastic syndromes
Pei-shan Wu, Annette E Hay, Giles E Thomas, et al.
BMC Medical Research Methodology
|
August 3, 2023
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
Louis Everest, Bingshu E Chen, Annette E Hay, et al.
BMJ Open
|
August 11, 2023
Augmenting clinical trial economic analysis by linking cancer trial data to administrative data: current landscape and future opportunities
Brooke E Wilson, Annette E Hay, Kelvin Kar-Wing Chan, et al.
Canadian Journal of Diabetes
|
January 11, 2024
Determining the Associations Between Glucocorticoid Use During Hematologic Chemotherapy Treatment and New-onset Diabetes and Hyperglycemia and Mortality: A Population-based Cohort Study
Sarah Moore-Vasram, Monakshi Sawhney, Robyn L Houlden, et al.
Leukemia & Lymphoma
|
July 10, 2024
Development and testing of a lymphoma clinical trial-specific frailty index: a secondary analysis of the NCIC-CTG LY.12 clinical trial
Abi Vijenthira, Xinzhi Li, Michael Crump, et al.
Current Oncology (Toronto, Ont.)
|
February 26, 2026
People Living with HIV Eligibility in Canadian Cancer Clinical Trials
Maria F Comelles, Santiago Perez-Patrigeon, Tessa Senneker, et al.
Page
of 6